-+ 0.00%
-+ 0.00%
-+ 0.00%

Spruce Biosciences FY2025 R&D expenses fell 57.97% to USD 19.5 million, net loss was USD 39 million

Reuters·03/20/2026 21:05:35

Please log in to view news